TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells
- 1 August 2006
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (12), 1881-1888
- https://doi.org/10.1016/j.ejca.2006.03.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletionNature, 2005
- POT1 and TRF2 Cooperate To Maintain Telomeric IntegrityMolecular and Cellular Biology, 2005
- Functional links between telomeres and proteins of the DNA-damage responseGenes & Development, 2004
- Glutathione Influences c-Myc-induced Apoptosis in M14 Human Melanoma CellsPublished by Elsevier BV ,2002
- Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clonesOncogene, 2002
- Targeting Assay To Study the cis Functions of Human Telomeric Proteins: Evidence for Inhibition of Telomerase by TRF1 and for Activation of Telomere Degradation by TRF2Molecular and Cellular Biology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2Nature Genetics, 1997
- Telomeric localization of TRF2, a novel human telobox proteinNature Genetics, 1997
- Antitumor Effect of c-myc Antisense Phosphorothioate Oligodeoxynucleotides on Human Melanoma Cells In Vitro and in MiceJNCI Journal of the National Cancer Institute, 1996